NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
This Quarter Return
+25.62%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.55B
AUM Growth
+$1.55B
(+3.4%)
Cap. Flow
-$228M
Cap. Flow
% of AUM
-14.71%
Top 10 Holdings %
Top 10 Hldgs %
80.86%
Holding
37
New
7
Increased
11
Reduced
7
Closed
2
Top Buys
| 1 |
Medtronic
MDT
|
$90.6M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
$60.5M |
| 3 |
Brookfield
BN
|
$33.7M |
| 4 |
Vaxcyte
PCVX
|
$27.9M |
| 5 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
$18.5M |
Top Sells
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$426M |
| 2 |
Cable One
CABO
|
$30.7M |
| 3 |
Akebia Therapeutics
AKBA
|
$19.1M |
| 4 |
Apple
AAPL
|
$10.7M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$7.12M |
Sector Composition
| 1 | Healthcare | 44.51% |
| 2 | Technology | 8.91% |
| 3 | Communication Services | 6.56% |
| 4 | Financials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Total Stock Market ETF
VTI
$526B
| $481M | 31.03% | 3,070,400 -2,720,000 | -47% | -$426M |
|
|
2
Apple
AAPL
$3.45T
| $138M | 8.91% | 378,226 -29,380 | -7% | -$10.7M |
|
3
Inogen
INGN
$216M
| $126M | 8.14% | 3,549,321 | – | – |
|
|
4
Cable One
CABO
$909M
| $102M | 6.56% | 57,291 -17,304 | -23% | -$30.7M |
|
|
5
Brookfield
BN
$98.3B
| $101M | 6.52% | 3,070,957 +1,023,652 | +50% | +$33.7M |
|
|
6
Medtronic
MDT
$119B
| $90.6M | 5.85% | +988,136 | New | +$90.6M |
|
|
MORF
7
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $71.6M | 4.62% | 2,645,446 | – | – |
|
|
CTLT
8
DELISTED
CATALENT, INC.
CTLT
| $60.5M | 3.9% | +824,739 | New | +$60.5M |
|
9
Mirum Pharmaceuticals
MIRM
$3.71B
| $47.6M | 3.07% | 2,445,147 | – | – |
|
10
Amicus Therapeutics
FOLD
$2.34B
| $35M | 2.26% | 2,320,026 | – | – |
|
|
11
Vaxcyte
PCVX
$4B
| $27.9M | 1.8% | +881,898 | New | +$27.9M |
|
|
12
Akebia Therapeutics
AKBA
$833M
| $27M | 1.74% | 1,987,506 -1,405,533 | -41% | -$19.1M |
|
|
GRTX
13
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $24.3M | 1.57% | 3,409,021 | – | – |
|
|
BPMC
14
DELISTED
Blueprint Medicines
BPMC
| $20M | 1.29% | 256,767 +22,500 | +10% | +$1.76M |
|
|
SPNE
15
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $18.7M | 1.21% | 1,790,431 +75,000 | +4% | +$785K |
|
|
FLXN
16
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $18.5M | 1.19% | +1,403,370 | New | +$18.5M |
|
17
SI-BONE Inc
SIBN
$719M
| $15.8M | 1.02% | 989,827 +18,437 | +2% | +$294K |
|
18
Protagonist Therapeutics
PTGX
$3.67B
| $14.6M | 0.94% | 824,169 +126,270 | +18% | +$2.23M |
|
|
CNST
19
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $13.1M | 0.85% | 437,131 +268,750 | +160% | +$8.08M |
|
20
Spero Therapeutics
SPRO
$116M
| $12.6M | 0.81% | 931,099 | – | – |
|
|
AERI
21
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $11.9M | 0.77% | 807,656 +56,682 | +8% | +$837K |
|
22
Insmed
INSM
$28.8B
| $11.8M | 0.76% | +430,107 | New | +$11.8M |
|
|
AKUS
23
DELISTED
Akouos, Inc. Common Stock
AKUS
| $10.5M | 0.68% | +467,786 | New | +$10.5M |
|
|
ZGNX
24
DELISTED
Zogenix, Inc.
ZGNX
| $8.8M | 0.57% | 325,814 +102,630 | +46% | +$2.77M |
|
25
Corvus Pharmaceuticals
CRVS
$428M
| $7.96M | 0.51% | 2,927,560 | – | – |
|